ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 135 filers reported holding ARGENX SE in Q3 2019. The put-call ratio across all filers is 0.80 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $9,766,000 | -53.6% | 27,889 | -84.9% | 1.12% | -54.8% |
| Q3 2019 | $21,041,000 | -29.4% | 184,631 | -12.2% | 2.48% | -15.1% |
| Q2 2019 | $29,784,000 | -11.8% | 210,372 | -22.2% | 2.93% | -35.1% |
| Q1 2019 | $33,775,000 | +21.2% | 270,548 | -6.8% | 4.52% | +7.4% |
| Q4 2018 | $27,878,000 | +36.5% | 290,181 | +7.7% | 4.20% | +195.0% |
| Q3 2018 | $20,426,000 | +21.9% | 269,325 | +33.1% | 1.42% | +21.8% |
| Q2 2018 | $16,762,000 | +25.5% | 202,293 | +21.9% | 1.17% | +10.9% |
| Q1 2018 | $13,354,000 | +139.6% | 166,011 | +88.1% | 1.06% | +193.9% |
| Q4 2017 | $5,573,000 | – | 88,269 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 273,343 | $106,529,967 | 17.42% |
| Kynam Capital Management, LP | 184,300 | $71,827,239 | 9.88% |
| Ikarian Capital, LLC | 132,100 | $51,483,333 | 8.20% |
| Avoro Capital Advisors LLC | 1,263,500 | $492,423,855 | 6.68% |
| Artia Global Partners LP | 46,438 | $18,098,282 | 6.24% |
| DCF Advisers, LLC | 25,700 | $10,016,061 | 5.29% |
| Bellevue Group AG | 923,284 | $359,831,473 | 5.13% |
| Eagle Health Investments LP | 64,400 | $25,098,612 | 4.69% |
| Paradigm Biocapital Advisors LP | 150,000 | $58,459,500 | 4.52% |
| Paradigm Biocapital Advisors LP | 142,259 | $55,442,600 | 4.28% |